Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Impaired Glucose Tolerance
Open-data reference.
14 US clinical trials · 4 currently recruiting
Active & Recent Trials
Night Owl Metabolism
Johns Hopkins University
NCT06507722
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
Yale University
NCT05067621
The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults
University of New Hampshire
NCT05912348
CGM and Lifestyle Changes in Patients With Impaired Glucose Tolerance
Nemours Children's Clinic
NCT05387551
The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African Americans
Ohio State University
NCT03938389
Improving Autonomic Function and Balance in Diabetic Neuropathy
VA Office of Research and Development
NCT01864460
To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
Novartis
NCT01068860
D Vitamin Intervention in VA
US Department of Veterans Affairs
NCT01375660
The Effect of Real Time Continuous Glucose Monitoring in Subjects With Pre-diabetes
Walter Reed National Military Medical Center
NCT01741467
Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT01030861
Effect of Dietary Glycemic Index on Beta-cell Function
Seattle Institute for Biomedical and Clinical Research
NCT01386645
Effects of an Intermittent Fasting and Dietary Supplement Regimen on Glycemic Variability
Unicity International
NCT05493553
The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
Beth Israel Deaconess Medical Center
NCT00456885
Sucralose, Stevia, Gut Microbiome and Glucose Metabolism
University of Minnesota
NCT02800707
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 4 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Impaired Glucose Tolerance Trial Landscape
ClinicalTrials.gov lists 14 US studies indexed under Impaired Glucose Tolerance, and 4 of those are currently open to recruitment — roughly 29% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Impaired Glucose Tolerance shows 2 late-stage studies (Phase 3 and Phase 4 combined) alongside 3 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Impaired Glucose Tolerance is led by Unicity International with 1 indexed trial, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 14 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Impaired Glucose Tolerance?
PlainTrial tracks 14 US clinical trials for Impaired Glucose Tolerance, of which 4 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Impaired Glucose Tolerance?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.